PMID: 9190288Feb 1, 1997Paper

Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA

Chemistry & Biology
B WolffY Wang

Abstract

The human immunodeficiency virus type 1 (HIV-1) regulatory protein Rev is required for unspliced and incompletely spliced viral mRNAs to appear in the cytoplasm and thus for viral replication. Translocation of Rev from the nucleus to the cytoplasm is essential if Rev is to function. We wanted to identify inhibitors of this transport process because they would be potential antiviral agents. The Streptomyces metabolite, leptomycin B, and other antibiotics of the leptomycin/kazusamycin family were identified as inhibitors of the nucleo-cytoplasmic translocation of Rev at nanomolar concentrations. Rev-dependent export of mRNA into the cytoplasm is also blocked by leptomycin B, which inhibits Rev-dependent, but not Rev-independent gene expression in a short-term transfection assay. In primary human monocytes, leptomycin B suppresses HIV-1 replication. Leptomycin B is the first low molecular weight inhibitor of nuclear export to be identified. Although it cannot be used therapeutically, it should serve as a valuable tool for dissecting nuclear export pathways.

References

Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·D BevecE Böhnlein
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·T J HopeT G Parslow
Mar 1, 1990·Experimental Cell Research·M YoshidaT Beppu
Jul 4, 1990·Journal of the National Cancer Institute·P SkehanM R Boyd
Aug 1, 1988·Journal of Virological Methods·R PauwelsE De Clercq
Aug 11, 1989·Cell·B R Cullen, W C Greene
May 1, 1989·Journal of Virology·M L HammarskjöldD Rekosh
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B K FelberG N Pavlakis
Sep 1, 1988·Genes & Development·H Varmus
Dec 1, 1988·The Journal of Antibiotics·K TakamiyaI Umezawa
Feb 1, 1988·Journal of Virology·E TerwilligerC Rosen
Nov 1, 1987·The Journal of Antibiotics·E YoshidaI Umezawa
Feb 1, 1985·The Journal of Antibiotics·K KomiyamaI Umezawa
Jun 1, 1983·The Journal of Antibiotics·T HamamotoT Beppu
Jul 1, 1994·Genes & Development·B E Meyer, M H Malim
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·L DuanR J Pomerantz
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·R A FridellB R Cullen

❮ Previous
Next ❯

Citations

Jan 21, 2012·Cellular and Molecular Life Sciences : CMLS·Karin HochrainerJosef Anrather
Sep 12, 2012·Medical Microbiology and Immunology·Nadine FrankenbergBodo Plachter
Jun 19, 2009·Medical Molecular Morphology·Tominori KimuraHisao Yamada
Sep 22, 2010·Medical Molecular Morphology·Tominori KimuraHisao Yamada
Apr 27, 2013·The Journal of Microbiology·Yong-Qiang FanYu-Long Wang
Dec 4, 2003·Experimental Cell Research·Séverine DemartRuth Brack-Werner
May 26, 2004·Methods : a Companion to Methods in Enzymology·Minoru Yoshida, Shelley Sazer
Mar 21, 2003·Biochemical and Biophysical Research Communications·Osvaldo ReyEnrique Rozengurt
Jan 18, 2003·Experimental Cell Research·Megan Fabbro, Beric R Henderson
May 17, 2003·Experimental Cell Research·Mario KösterHansjörg Hauser
Jun 6, 2003·Advanced Drug Delivery Reviews·Joshua Z Gasiorowski, David A Dean
Jun 20, 2002·Human Immunology·Jonathan A HartonJenny P-Y Ting
Jun 26, 1998·Current Opinion in Cell Biology·L F PembertonJ S Rosenblum
Jun 26, 1998·Current Opinion in Cell Biology·J E Dahlberg, E Lund
Aug 8, 1998·Trends in Cell Biology·R W WozniakJ D Aitchison
Oct 28, 1998·Trends in Cell Biology·B HendersonJ Hyams
Jun 5, 1998·Trends in Biochemical Sciences·K Weis
Aug 4, 1999·Trends in Biochemical Sciences·C M Crews, U Splittgerber
Jan 26, 1999·Cytokine & Growth Factor Reviews·T Sekimoto, Y Yoneda
Feb 5, 2003·Drug Discovery Today·Tweeny R Kau, Pamela A Silver
Nov 13, 2001·Developmental Cell·E FormstecherH Chneiweiss
Oct 26, 2010·Nature Structural & Molecular Biology·Thomas GüttlerDirk Görlich
Dec 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Daniela CastanottoJohn J Rossi
Aug 4, 2010·Proceedings of the National Academy of Sciences of the United States of America·Venkat S R K Yedavalli, Kuan-Teh Jeang
May 12, 2010·The Journal of Biological Chemistry·Mark HilliardRalph H Kehlenbach
Sep 16, 2010·The Journal of Biological Chemistry·Fang ZhouRongjia Zhou
Oct 26, 2012·The Journal of Biological Chemistry·Khue TruongYuan Chen
Dec 18, 2012·Molecular & Cellular Proteomics : MCP·Ketan ThakarRalph H Kehlenbach
May 1, 2004·The Journal of Experimental Medicine·Kevin M McBrideMichel C Nussenzweig
Feb 16, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Nancy C Reich
Jul 20, 2007·Assay and Drug Development Technologies·Fabian ZanellaWolfgang Link
May 18, 2004·Molecular Biology of the Cell·Jinming GuEllen Fanning
Apr 9, 2005·Molecular Biology of the Cell·Sten StrunzeUrs F Greber
Jan 21, 2012·Molecular Biology of the Cell·J Bradley ZucheroR Dyche Mullins
Jul 21, 2001·EMBO Reports·A NeiningerM Gaestel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.